Evaluation of the Impact of the COVID-19 Pandemic on the Incidence of Cancer: A Comparative Analysis between the Years 2018 and 2022
DOI:
https://doi.org/10.14738/bjhr.1201.18339Keywords:
Pandemic (D058873), Covid-19 (D000086382), Cancer (D009369)Abstract
Background: The SARS-CoV-2 pandemic has caused unprecedented medical, social, and economic challenges, resulting in lockdowns, travel restrictions, social isolation, and distancing measures. Some research studies have shed some light on how this pandemic has influenced cancer screening and treatment services, highlighting the urgent need to continue to assess incidence rates during this period. Objective: To evaluate the incidence of cancer pre and post-COVID-19 Pandemic in a highly specialized hospital. Methods: Descriptive, Cross-sectional, Retrospective Study. We studied all biopsy reports of cancer from the highly specialized hospital Pathology Department between 2018 and 2022. Results: The results of 8804 biopsies were analyzed. In 2018, 4379 were examined, of which 1622 were benign specimens, and 2757 (62.95%) were diagnosed with malignancy. In 2022, 4425 were studied, of which 1209 were diagnosed with benignity and 3216 (72.68%) were malignant. Conclusion: Compared to the pre-pandemic year and the post-pandemic year, reports of biopsies with malignancy diagnoses increased.
References
Ledford H. Metabolic quirks yield tumor hope. Nature. 2014;508(7495):158–9.
Organizacion Mundial de la Salud. Sitio web mundial. Cáncer [Internet]. 2022. Disponible en: https://www.who.int/es/health-topics/cancer#tab=tab_1
Jones PA, Baylin SB. The Epigenomics of Cancer. Cell. 2007;128(4):683–92.
Gilbertson RJ. Mapping Cancer Origins. Cell. 2011;145(1):25–9.
Brau-Figueroa H, Palafox-Parrilla EA, Mohar-Betancourt A. El Registro Nacional de Cáncer en México, una realidad. Gac Mex Oncol. 2020;19(3):107-111.
Mazidimoradi A, Tiznobaik A, Salehiniya H. Impact of the COVID-19 Pandemic on Colorectal Cancer Screening: a Systematic Review. J Gastrointest Cancer. 2022;53(3):730-744.
Suárez J, Mata E, Guerra A, Jiménez G, Montes M, Arias F, et al. Impact of the COVID‐19 pandemic during Spain’s state of emergency on the diagnosis of colorectal cancer. J Surg Oncol. 2021;123(1):32–6.
Seo SH, Cho S, Yoo SH, Keam B, Shin A. Changes in the Utilization of Health Care Services by Cancer Patients during the COVID-19 Pandemic. Yonsei Med J. 2023;64(7):463.
Masroor S. Collateral damage of COVID‐19 pandemic: Delayed medical care. J Card Surg. 2020;35(6):1345–7.
Zhu H, Wei L, Niu P. The novel coronavirus outbreak in Wuhan, China. Glob Health Res Policy. 2020;5(1):6.
Boettcher AN, Hammoud DA, Weinberg JB, Agarwal P, Mendiratta-Lala M, Luker GD. Cancer Imaging and Patient Care during the COVID-19 Pandemic. Radiol Imaging Cancer. 2020;2(6):e200058.
Walker MJ, Meggetto O, Gao J, Espino-Hernández G, Jembere N, Bravo C, et al. Measuring the impact of the COVID-19 pandemic on organized cancer screening and diagnostic follow-up care in Ontario, Canada: A provincial, population-based study. Prev Med. 2021;151:106586.
Chen RC, Haynes K, Du S, Barron J, Katz AJ. Association of Cancer Screening Deficit in the United States With the COVID-19 Pandemic. JAMA Oncol. 2021;7(6):878.
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69(1):7–34.
Siegel RL, Wagle NS, Cercek A, Smith RA, Jemal A. Colorectal Cancer statistics, 2023. CA Cancer J Clin. 2023;73: 233–54. 339
Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer Statistics, 2021. CA Cancer J Clin. 2021;71(1):7–33.
Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72(1):7–33.
Jikihara S, Hoshino N, Hida K, Inamoto S, Tanaka E, Matsusue R, et al. Impact of the coronavirus disease 2019 pandemic on gastric and colorectal cancer surgeries: a multicenter epidemiologic study from the Kinki region of Japan. Surg Today. 2024; 54: 86–9
Terashima T, Konishi H, Sato Y, Igarashi M, Yanagibashi T, Konno R, et al. Impact of coronavirus disease 2019 on the number of newly diagnosed cancer patients and examinations and surgeries performed for cancer in Japan: a nationwide study. BMC Cancer. 2022; 22(1):1303.
Kuzuu K, Misawa N, Ashikari K, Kessoku T, Kato S, Hosono K, et al. Gastrointestinal Cancer Stage at Diagnosis Before and During the COVID-19 Pandemic in Japan. JAMA Netw Open. 2021; 4(9):e2126334.
Rottoli M, Gori A, Pellino G, Flacco ME, Martellucci C, Spinelli A, et al. Colorectal Cancer Stage at Diagnosis Before vs During the COVID-19 Pandemic in Italy. JAMA Netw Open. 2022;5(11):e2243119.
Aboueshia M, Hussein MH, Attia AS, Swinford A, Miller P, Omar M, et al. Cancer and COVID-19: analysis of patient outcomes. Future Oncology. 2021;17(26):3499–510.
Padilla-Raygoza N, Monroy-Torres R, Sandoval-Salazar C, Vera-Becerra LE, Patiño-López ME, García-Campos M, et al. Cancer prevention programmes in Mexico: are we doing enough? Ecancer. 2020;14:1-21.
Ignacio-Ibarra G, Espinoza-Zamora JR, Ramírez-Alvarado AG, Ceballos-López AA. Mieloma múltiple en tiempos de SARS-CoV-2 (COVID-19) en México. Gac Med Mex. 2021;157(Supl 3):S141-S147.
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68(1):7–30.
Zhang Y, Guo Y, Zhang C. A bibliometric study of the top 100 most cited papers on aging and cancer. Medicine. 2023;102:32(e34428).
Riquelme-Heras H, Ramirez-Aranda J, Gutierrez-Herrera R, Sierra-Ayala I, Saenz-Saucedo I, Nielsen-Fonseca S, et al. Comparison of pre and post-pandemic general morbidity in primary care. Am J Med Surg. 2024; 15 (1):31-6.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Dr. Hector Riquelme-Heras, Dr. Marcelo Zarate-Escamilla, Dr. Raul Gutierrez-Herrera, Dr. Isauro Saenz-Saucedo, Dra. Yeyetzy Ordoñez-Azuara, MIP Salma Nielsen-Fonseca
This work is licensed under a Creative Commons Attribution 4.0 International License.
